Stockreport

AMAG Pharmaceuticals Announces FDA Approval of Makena® (hydroxyprogesterone caproate injection) Subcutaneous Auto-Injector to Reduce the Risk of Preterm Birth in Certain At-Risk Women

AMAG PHARMACEUTICALS  (AMAG) 
Last amag pharmaceuticals earnings: 3/4 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: amagpharma.com/investors
PDF WALTHAM, Mass., Feb. 14, 2018 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that the U.S. Food and Drug Administration (FDA) approved th [Read more]